Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/28/2015 08/31/2015 09/01/2015 09/02/2015 09/03/2015 Date
3.64(c) 3.63(c) 3.62(c) 3.77(c) 3.68(c) Last
382 383 490 175 539 598 302 647 407 986 Volume
-0.55% -0.27% -0.28% +4.14% -2.39% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -21,8 M
Net income 2015 -22,4 M
Debt 2015 -
Yield 2015 -
Sales 2016 15,6 M
EBIT 2016 -15,7 M
Net income 2016 -15,8 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 19,9x
Capitalization 311 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109.The company was founded by McEnany J. Patrick... 
Sector
Biotechnology & Medical Research
Calendar
09/10 | 10:00amPresentation
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
08:22a CATALYST PHARMACEUTICALS : to Present at Rodman & Renshaw's 17th Annual Global I..
08:04a Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 17th Annual G..
08/19 CATALYST PHARMACEUTICALS : Nasdaq: CPRX) to Ring The Nasdaq Stock Market Closing..
08/19 CATALYST PHARMACEUTICALS : Nasdaq: CPRX) to Ring The Nasdaq Stock Market Closing..
08/17 Catalyst Pharmaceuticals Appoints Paul J. Merrigan as Chief Commercial Office..
08/11 CATALYST PHARMACEUTICALS : reports second-quarter net loss, plans to submit new ..
08/11 CATALYST PHARMACEUTICALS : Announces Second Quarter 2015 Financial Results and P..
08/10 CATALYST PHARMACEUTICALS : reports 2Q loss
More news
Sector news : Bio Therapeutic Drugs
08:01a QUINTILES TRANSNATIONAL : CEO to Present at Morgan Stanley Global Healthcare Con..
07:37a QIAGEN NV : kit isolates high-quality RNA from exosomes in liquid biopsies
07:01a ISIS PHARMACEUTICALS : to Present at Upcoming Investor Conferences
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/21 Time To Load Up On Biotechs?
08/17 New commercial chief at Catalyst Pharma
08/11 Catalyst Pharmaceuticals' (CPRX) CEO Patrick McEnany on Q2 2015 Results - Ear..
08/10 Catalyst Pharmaceutical beats by $0.02
07/22 Catalyst Pharma starts rolling NDA submission for Firdapse in LEMS


Comments 
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions